Table VII. Patients with primary diagnosis of other cholestatic by linear growth impairment at last follow-up visit.
| Linear growth failure at last visit | ||||||
|---|---|---|---|---|---|---|
|
|
||||||
| Total | No | Yes | ||||
|
|
|
|
||||
| Other cholestatic | n | % | n | % | n | % |
| Total | 142 | 100.0 | 84 | 100.0 | 58 | 100.0 |
| Alagille syndrome | 34 | 23.9 | 19 | 22.6 | 15 | 25.9 |
| Byler disease and Familial cholestasis/cirrhosis | 19 | 13.4 | 11 | 13.1 | 8 | 13.8 |
| Idiopathic cholestasis/cirrhosis | 14 | 9.9 | 6 | 7.1 | 8 | 13.8 |
| Total parenteral nutrition induced | 5 | 3.5 | 1 | 1.2 | 4 | 6.9 |
| Primary sclerosing cholangitis | 41 | 28.9 | 27 | 14 | 32.1 | 24.1 |
| Biliary strictures | 2 | 1.4 | 2 | 2.4 | 0 | 0.0 |
| Neonatal hepatitis | 7 | 4.9 | 5 | 6.0 | 2 | 3.4 |
| Other cholestatic | 20 | 14.1 | 13 | 15.5 | 7 | 12.1 |